Clinical Trial Update: Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan

View source ↗

Summary

This clinical trial update indicates the study NCT00602147, investigating genetic mutations related to mucositis in multiple myeloma patients treated with high-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Alkeran (melphalan)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Mucositis, Multiple Myeloma and Plasma Cell Neoplasm | Status: TERMINATED